- Home
- VATE vs CLNN Comparison
VATE vs CLNN Comparison
Compare VATE & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- CLNN
- Stock Information
- Founded
- VATE 1994
- CLNN 2012
- Country
- VATE United States
- CLNN United States
- Employees
- VATE N/A
- CLNN N/A
- Industry
- VATE Metal Fabrications
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- CLNN Health Care
- Exchange
- VATE Nasdaq
- CLNN Nasdaq
- Market Cap
- VATE 62.0M
- CLNN 60.3M
- IPO Year
- VATE 1996
- CLNN N/A
- Fundamental
- Price
- VATE $5.39
- CLNN $8.54
- Analyst Decision
- VATE
- CLNN Strong Buy
- Analyst Count
- VATE 0
- CLNN 6
- Target Price
- VATE N/A
- CLNN $32.67
- AVG Volume (30 Days)
- VATE 48.1K
- CLNN 149.3K
- Earning Date
- VATE 11-12-2025
- CLNN 11-12-2025
- Dividend Yield
- VATE N/A
- CLNN N/A
- EPS Growth
- VATE N/A
- CLNN N/A
- EPS
- VATE N/A
- CLNN N/A
- Revenue
- VATE $995,000,000.00
- CLNN $286,000.00
- Revenue This Year
- VATE N/A
- CLNN N/A
- Revenue Next Year
- VATE N/A
- CLNN $1,363.77
- P/E Ratio
- VATE N/A
- CLNN N/A
- Revenue Growth
- VATE N/A
- CLNN N/A
- 52 Week Low
- VATE $3.71
- CLNN $2.28
- 52 Week High
- VATE $13.79
- CLNN $11.06
- Technical
- Relative Strength Index (RSI)
- VATE 67.65
- CLNN 57.26
- Support Level
- VATE $4.38
- CLNN $7.66
- Resistance Level
- VATE $5.50
- CLNN $8.58
- Average True Range (ATR)
- VATE 0.34
- CLNN 0.81
- MACD
- VATE 0.15
- CLNN -0.13
- Stochastic Oscillator
- VATE 98.06
- CLNN 51.20
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.